The clinical management of patients after allogeneic bone marrow transplantation is often complicated. Patients frequently develop clinical signs of acute graft versus host disease in the early days of marrow engraftment, a time when they are also severely neutropenic. ' One of the first signs of the disease is an isolated fever and it can be extremely difficult to assess clinically whether the fever reflects graft versus host disease, infection, or both.
C reactive protein is the classical acute phase reactant, the serum concentration of which rises by up to several thousand fold after most fonns of tissue damage, infection, inflammation, and malignant neoplasia.24 Recent studies have shown that in patients who are neutropenic after treatment of leukaemia the serum C reactive protein concentration increases substantially in association with clinically or microbiologically documented episodes of infection.57 The persistence of a raised C reactive protein concentration correlates with continuing infection. In contrast, the leukaemic process per se, or its treatment, is associated with only a small, if any, rise in C reactive protein concentration.7
The aim of the present study was to determine whether the C reactive protein concentration was Accepted for publication 24 November 1983 increased in patients with graft versus host disease and to assess the clinical value of serial C reactive protein measurements in patients after bone marrow transplantation.
Patients and methods
Nineteen patients with leukaemia underwent intensive chemotherapy and total body irradiation and then received bone marrow harvested from HLA identical, mixed lymphocyte reaction unreactive siblings (Table) Graft versus host disease was diagnosed clinically by the documentation of rash and severe diarrhoea or liver function abnormalities or both, according to the criteria of the Seattle Bone Marrow Transplantation Group.' Whenever possible the disease was confirmed histologically in skin biopsy specimens.
Venous blood was taken for C reactive protein estimation on two or three occasions in the week before transplant, then daily from the day of transplant until the patient was no longer neutropenic (neutrophils >1 x 109/l), and thereafter whenever practicable, until the patient was discharged from hospital. Serum was stored at -20°C and assayed for C reactive protein by electroimmunoassay as described elsewhere.8 The assays were standardised using samples of isolated pure C reactive protein; the coefficients of variation of replicate samples both within and between assays did not exceed 1 0%. swabs. A further case of oral mucositis, which clinically appeared to be caused by Herpes simplex despite negative cultures, responded to treatment with intravenous acyclovir. Six febrile episodes were associated with bacterial infections, with isolation from blood cultures of Staphylococcus epidermidis in four patients, Staphylococcus aureus in one patient, and enterobacter in one patient. Seven febrile episodes were associated with concomitant graft versus host disease and infection, and in these patients the C reactive protein concentration was of no use in distinguishing the cause of fever (Fig. 3) . In addition, one patient had a rise in C reactive protein concentration associated with a sore throat (from which pseudomonas was isolated) without fever and responded to netilmycin therapy. Two patients had Herpes simplex stomatitis with positive cultures associated with no fever and no rise in C reactive protein concentration.
Discussion
In this study all febrile patients with graft versus host disease in the absence of infection had increased serum C reactive protein concentrations, and the concentrations fell as the episodes of graft versus host disease resolved. Some episodes of graft versus host disease are associated with infection, and it is possible that the process of infection precipitates the 
